Gayatri BioOrganics (GAYATRIBI) | Financial Analysis & Statements
Gayatri BioOrganics Ltd. Small-cap Basic Materials
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
0
Gross Profit
0
Operating Income
-1.8M
Net Income
-2.6M
EPS (Diluted)
₹-0.03
Balance Sheet Metrics
Total Assets
16.6M
Total Liabilities
375.6M
Shareholders Equity
-358.9M
Cash Flow Metrics
Revenue & Profitability Trend
Gayatri BioOrganics Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 16.7M | 0 | 0 |
| Cost of Goods Sold | 0 | 0 | 15.9M | 0 | 0 |
| Gross Profit | 0 | 0 | 798.0K | 0 | 0 |
| Gross Margin % | 0.0% | 0.0% | 4.8% | 0.0% | 0.0% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 2.9M | 2.8M | 2.5M | 1.6M | 1.3M |
| Other Operating Expenses | 489.0K | 955.0K | 2.0M | 260.0K | 703.0K |
| Total Operating Expenses | 3.4M | 3.7M | 4.5M | 1.9M | 2.0M |
| Operating Income | -4.5M | -5.0M | -5.3M | -5.0M | -5.0M |
| Operating Margin % | 0.0% | 0.0% | -31.9% | 0.0% | 0.0% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | 0 | 0 |
| Interest Expense | 2.8M | 1.5M | 276.0K | 3.0K | 3.0K |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | -7.3M | -6.8M | -8.0M | -5.0M | -5.0M |
| Income Tax | 0 | 0 | 2.1M | 0 | 0 |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Income | -7.3M | -6.8M | -10.1M | -5.0M | -5.0M |
| Net Margin % | 0.0% | 0.0% | -60.6% | 0.0% | 0.0% |
| Key Metrics | |||||
| EBITDA | -4.5M | -5.3M | -5.7M | -5.0M | -5.0M |
| EPS (Basic) | ₹-0.09 | ₹-0.09 | ₹-0.13 | ₹-0.06 | ₹-0.06 |
| EPS (Diluted) | ₹-0.09 | ₹-0.09 | ₹-0.13 | ₹-0.06 | ₹-0.06 |
| Basic Shares Outstanding | 78788142 | 78788142 | 78788142 | 78788142 | 78788142 |
| Diluted Shares Outstanding | 78788142 | 78788142 | 78788142 | 78788142 | 78788142 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Gayatri BioOrganics Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 205.0K | 310.0K | 250.0K | 329.0K | 4.4M |
| Short-term Investments | - | - | - | 1.2M | 1.2M |
| Accounts Receivable | 2.5M | 2.5M | 2.5M | 4.8M | 4.8M |
| Inventory | - | - | - | - | - |
| Other Current Assets | 13.9M | 12.9M | 13.4M | 15.1M | 14.6M |
| Total Current Assets | 16.6M | 15.8M | 16.2M | 21.4M | 25.0M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | - | - | - | - | - |
| Goodwill | - | - | - | - | - |
| Intangible Assets | - | - | - | - | - |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | - | - | - | - | - |
| Total Non-Current Assets | 0 | 0 | 0 | 921.0K | 921.0K |
| Total Assets | 16.6M | 15.8M | 16.2M | 22.4M | 25.9M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 2.0M | 1.8M | 2.1M | 4.7M | 4.4M |
| Short-term Debt | 334.0M | 334.0M | 334.0M | 334.0M | 334.0M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 258.0K | 278.0K | 772.0K | 295.0K | 138.0K |
| Total Current Liabilities | 340.6M | 337.9M | 338.4M | 340.1M | 338.7M |
| Non-Current Liabilities | |||||
| Long-term Debt | 35.0M | 29.6M | 22.6M | 17.0M | 17.0M |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | 1.0K | - | - | - | 1.0K |
| Total Non-Current Liabilities | 35.0M | 29.6M | 22.6M | 17.0M | 17.0M |
| Total Liabilities | 375.6M | 367.4M | 361.0M | 357.1M | 355.7M |
| Equity | |||||
| Common Stock | 787.9M | 787.9M | 787.9M | 787.9M | 787.9M |
| Retained Earnings | -1.2B | -1.2B | -1.2B | -1.2B | -1.1B |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | -358.9M | -351.7M | -344.9M | -334.8M | -329.8M |
| Key Metrics | |||||
| Total Debt | 369.0M | 363.6M | 356.6M | 351.1M | 351.1M |
| Working Capital | -324.0M | -322.1M | -322.3M | -318.7M | -313.7M |
Balance Sheet Composition
Gayatri BioOrganics Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -7.3M | -6.8M | -10.1M | -5.0M | -5.0M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | -1.3M | -1.3M | 6.8M | 641.0K | -172.0K |
| Operating Cash Flow | -5.8M | -6.6M | -3.1M | -4.3M | -5.1M |
| Investing Activities | |||||
| Capital Expenditures | - | - | - | - | - |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | - | - | - | - | - |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 5.4M | 7.0M | 5.6M | - | - |
| Debt Repayment | 0 | 0 | -5.6M | - | - |
| Financing Cash Flow | 5.4M | 7.0M | 0 | 0 | - |
| Free Cash Flow | -5.5M | -6.9M | -5.6M | -4.0M | -5.2M |
| Net Change in Cash | -360.0K | 426.0K | -3.1M | -4.3M | -5.1M |
Cash Flow Trend
Gayatri BioOrganics Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
0.59
Price to Book
-3.30
PEG Ratio
0.01
Profitability Ratios
Profit Margin
0.00%
Operating Margin
0.00%
Return on Equity
2.02%
Return on Assets
-43.67%
Financial Health
Current Ratio
0.05
Debt to Equity
-1.03
Beta
0.55
Per Share Data
EPS (TTM)
₹-0.11
Book Value per Share
₹-5.16
Revenue per Share
₹0.00
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| GAYATRIBI | 1.3B | 0.59 | -3.30 | 2.02% | 0.00% | -1.03 |
| Navin Fluorine | 322.4B | 57.84 | 8.89 | 10.99% | 17.74% | 32.68 |
| Deepak Nitrite | 230.5B | 43.19 | 4.18 | 12.85% | 6.71% | 22.41 |
| Ghcl | 46.2B | 9.54 | 1.33 | 17.89% | 16.60% | 2.66 |
| Styrenix Performance | 41.0B | 24.75 | 3.29 | 20.14% | 4.66% | 44.08 |
| Chemplast Sanmar | 38.6B | 210.40 | 2.02 | -5.34% | -7.01% | 96.73 |
Financial data is updated regularly. All figures are in the company's reporting currency.





